Unknown

Dataset Information

0

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.


ABSTRACT: Although radiation therapy (RT) plays a critical role in the treatment of low-grade glioma (LGG), many patients suffer from adverse effects without experiencing survival benefits. In various carcinomas, long non-coding RNAs (lncRNAs) contribute to pathogenic processes, including tumorigenesis, metastasis, chemoresistance, and radioresistance. Currently, the role of lncRNAs in the radiosensitivity of LGG is largely unknown. Here, we downloaded clinical data for 167 LGG patients from The Cancer Genome Atlas database and divided them between radiosensitive and radioresistant groups based on their clinical outcomes after receiving radiotherapy. We identified 37 lncRNAs that were differentially expressed (DElncRNAs) between the groups. Functional enrichment analysis revealed that their potential target mRNAs were mainly enriched in the PI3K-Akt and MAPK signaling pathways and in DNA damage response. Kaplan-Meier survival analysis revealed that increased expression of six lncRNAs was significantly associated with radiosensitivity. We then developed a risk signature based on three of the DElncRNAs that served as an independent biomarker for predicting LGG patient outcomes after radiotherapy. In vitro experiments further validated the biological function of these lncRNAs on low-grade glioma radiation response.

SUBMITTER: Lin W 

PROVIDER: S-EPMC7288909 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.

Lin Wanzun W   Huang Zongwei Z   Huang Zongwei Z   Xu Yanyan Y   Chen Xiaochuan X   Chen Ting T   Ye Yuling Y   Ding Jianming J   Chen Zhangjie Z   Chen Long L   Qiu Xianxin X   Qiu Sufang S  

Aging 20200526 10


Although radiation therapy (RT) plays a critical role in the treatment of low-grade glioma (LGG), many patients suffer from adverse effects without experiencing survival benefits. In various carcinomas, long non-coding RNAs (lncRNAs) contribute to pathogenic processes, including tumorigenesis, metastasis, chemoresistance, and radioresistance. Currently, the role of lncRNAs in the radiosensitivity of LGG is largely unknown. Here, we downloaded clinical data for 167 LGG patients from The Cancer Ge  ...[more]

Similar Datasets

| S-EPMC7876581 | biostudies-literature
| S-EPMC9909527 | biostudies-literature
| S-EPMC7683673 | biostudies-literature
| S-EPMC6697914 | biostudies-literature
| S-EPMC10791469 | biostudies-literature
| S-EPMC8444979 | biostudies-literature
| S-EPMC5961156 | biostudies-literature
| S-EPMC6196600 | biostudies-literature
| S-EPMC8019920 | biostudies-literature
| S-EPMC9640744 | biostudies-literature